Plus Therapeutics (PSTV) Short-term Investments (2024 - 2026)

Plus Therapeutics (PSTV) has 3 years of Short-term Investments data on file, last reported at $12.1 million in Q1 2026.

• Short-term Investments for Q1 2026 came in at $12.1 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $12.1 million (changed N/A YoY), and the FY2025 annual result was $4.4 million, up 23.4% from the prior year.
• Short-term Investments advanced to $12.1 million in Q1 2026 per PSTV's latest filing, from $4.4 million in the prior quarter.
• Over five years, Short-term Investments peaked at $12.1 million in Q1 2026 and troughed at $323000.0 in Q1 2024.
• A 3-year average of $4.4 million and a median of $3.5 million in 2024 frame the typical range for Short-term Investments.
• On a YoY basis, Short-term Investments climbed as much as 31.88% in 2025 and fell as far as 7.1% in 2025.
• A 3-year view of Short-term Investments shows it stood at $3.5 million in 2024, then advanced by 23.4% to $4.4 million in 2025, then surged by 177.59% to $12.1 million in 2026.
• Business Quant data shows PSTV's Short-term Investments at $12.1 million in Q1 2026, $4.4 million in Q4 2025, and $3.3 million in Q3 2025.